392 related articles for article (PubMed ID: 19171898)
1. Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse.
Liu B; Turley SD; Burns DK; Miller AM; Repa JJ; Dietschy JM
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2377-82. PubMed ID: 19171898
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid.
Liu B; Ramirez CM; Miller AM; Repa JJ; Turley SD; Dietschy JM
J Lipid Res; 2010 May; 51(5):933-44. PubMed ID: 19965601
[TBL] [Abstract][Full Text] [Related]
3. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.
Ramirez CM; Liu B; Taylor AM; Repa JJ; Burns DK; Weinberg AG; Turley SD; Dietschy JM
Pediatr Res; 2010 Oct; 68(4):309-15. PubMed ID: 20581737
[TBL] [Abstract][Full Text] [Related]
4. Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.
Lopez AM; Terpack SJ; Posey KS; Liu B; Ramirez CM; Turley SD
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):780-7. PubMed ID: 25115571
[TBL] [Abstract][Full Text] [Related]
5. Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream.
Taylor AM; Liu B; Mari Y; Liu B; Repa JJ
J Lipid Res; 2012 Nov; 53(11):2331-42. PubMed ID: 22892156
[TBL] [Abstract][Full Text] [Related]
6. Unesterified cholesterol accumulation in late endosomes/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment.
Aqul A; Liu B; Ramirez CM; Pieper AA; Estill SJ; Burns DK; Liu B; Repa JJ; Turley SD; Dietschy JM
J Neurosci; 2011 Jun; 31(25):9404-13. PubMed ID: 21697390
[TBL] [Abstract][Full Text] [Related]
7. Normalization of cholesterol homeostasis by 2-hydroxypropyl-β-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice.
Peake KB; Vance JE
J Biol Chem; 2012 Mar; 287(12):9290-8. PubMed ID: 22277650
[TBL] [Abstract][Full Text] [Related]
8. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo.
Neufeld EB; Wastney M; Patel S; Suresh S; Cooney AM; Dwyer NK; Roff CF; Ohno K; Morris JA; Carstea ED; Incardona JP; Strauss JF; Vanier MT; Patterson MC; Brady RO; Pentchev PG; Blanchette-Mackie EJ
J Biol Chem; 1999 Apr; 274(14):9627-35. PubMed ID: 10092649
[TBL] [Abstract][Full Text] [Related]
9. Niemann-Pick C1-deficient mice lacking sterol O-acyltransferase 2 have less hepatic cholesterol entrapment and improved liver function.
Lopez AM; Jones RD; Repa JJ; Turley SD
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G454-G463. PubMed ID: 29878847
[TBL] [Abstract][Full Text] [Related]
10. Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations.
Ramirez CM; Liu B; Aqul A; Taylor AM; Repa JJ; Turley SD; Dietschy JM
J Lipid Res; 2011 Apr; 52(4):688-98. PubMed ID: 21289032
[TBL] [Abstract][Full Text] [Related]
11. Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.
Nicoli ER; Al Eisa N; Cluzeau CV; Wassif CA; Gray J; Burkert KR; Smith DA; Morris L; Cologna SM; Peer CJ; Sissung TM; Uscatu CD; Figg WD; Pavan WJ; Vite CH; Porter FD; Platt FM
PLoS One; 2016; 11(3):e0152007. PubMed ID: 27019000
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells.
Abi-Mosleh L; Infante RE; Radhakrishnan A; Goldstein JL; Brown MS
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19316-21. PubMed ID: 19884502
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol accumulation and liver cell death in mice with Niemann-Pick type C disease.
Beltroy EP; Richardson JA; Horton JD; Turley SD; Dietschy JM
Hepatology; 2005 Oct; 42(4):886-93. PubMed ID: 16175610
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the sterol-trafficking defect in Niemann-Pick C disease.
Sturley SL; Patterson MC; Pentchev P
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2093-4. PubMed ID: 19211789
[No Abstract] [Full Text] [Related]
15. Delineation of metabolic responses of Npc1
Ramirez CM; Taylor AM; Lopez AM; Repa JJ; Turley SD
Steroids; 2020 Dec; 164():108725. PubMed ID: 32890578
[TBL] [Abstract][Full Text] [Related]
16. Function of the Niemann-Pick type C proteins and their bypass by cyclodextrin.
Vance JE; Peake KB
Curr Opin Lipidol; 2011 Jun; 22(3):204-9. PubMed ID: 21412152
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse.
Repa JJ; Li H; Frank-Cannon TC; Valasek MA; Turley SD; Tansey MG; Dietschy JM
J Neurosci; 2007 Dec; 27(52):14470-80. PubMed ID: 18160655
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ.
Xie C; Turley SD; Dietschy JM
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11992-7. PubMed ID: 10518564
[TBL] [Abstract][Full Text] [Related]
19. Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.
Cluzeau CV; Watkins-Chow DE; Fu R; Borate B; Yanjanin N; Dail MK; Davidson CD; Walkley SU; Ory DS; Wassif CA; Pavan WJ; Porter FD
Hum Mol Genet; 2012 Aug; 21(16):3632-46. PubMed ID: 22619379
[TBL] [Abstract][Full Text] [Related]
20. Characterization of liver disease and lipid metabolism in the Niemann-Pick C1 mouse.
Garver WS; Jelinek D; Oyarzo JN; Flynn J; Zuckerman M; Krishnan K; Chung BH; Heidenreich RA
J Cell Biochem; 2007 May; 101(2):498-516. PubMed ID: 17216601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
